chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a non-medical healthcare worker via company representative refers to a 12 months old female patient who did not feel well before receiving the vaccine. On unknown date the patient was vaccinated with a dose of M-M-R II (dose, lot #, expiration date and route were not reported). On unknown date 10 days after receiving the vaccine the patient was diagnosed with measles. The laboratory confirmed that the patient was experiencing a vaccine related case of measles versus wild type. The patient sought medical attention by office visit on unspecified date. It was not specified if the patient would receive subsequent doses of M-M-R II, due to this event. At the time, of the report the outcome of measles was unknown. Additional information has been requested.
Information has been received from a medical assistant concerning a 14 month old female who on approximately 2/5/99, was vaccinated with a dose of MMR II. The pt "broke out in hives after the dose had been given." Follow-up info received from a registered nurse indicated that twenty-four hours after vaccination, on 2/6/02, the pt developed hives. The pt recovered on an unknown date. Additional info is not expected.
Patient with 2 Moderna COVID vaccinations, last dose 03/24/21, who admitted to the hospital with an incarcerated hernia and hypovolemic shock who incidentally tested detected for COVID during admission testing.  No s/s of COVID during her stay.  Provider d/c note below:  "72-year-old female with a longstanding ventral incisional hernia in the low midline and an umbilical hernia. The patient presented to the ED on 2/24 with reported emesis for two weeks and LLQ abdominal pain. She was found to have hypovolemic shock secondary to small-bowel obstruction at the lower ventral hernia. The patient was also in atrial fibrillation with rapid ventricular response. She was admitted to the ICU, resuscitated, and converted back to normal sinus rhythm. The patient was taken to the operating theatre on 2/25/22 with doctor and underwent open ventral hernia repair with mesh placement. After surgery was performed without complication, the patient returned to the ICU intubated and sedated as she had difficulty weaning from the vent. She had a prevena device in place, two JP drains, as well as NGT. The patient required norepinephrine for hypotension. Patient extubated POD #2 and weaned off pressors on POD #7 and then transferred to the post operative floor. Midline staples and left JP drain removed POD #12. Patient continued to tolerate soft diet with good bowel function. She was admitted to Inpatient Rehabilitation. Right lower quadrant JP drain will remain in place when patient is discharged."
Severe pain in right shoulder. Limited movement. Fever. Chills. Sweats. Fatigue, loss of appetite. Nauseous. Unable to sleep. NORCO from my back surgery. Meloxicam arrived the next day. Ice. Cool cloth on my head. Heat when chilled. Bed rest when could get comfortable. Fluids. Most symptoms have slowly decreased. 3 1/2 days later. The pain was severe and now is moderate. Still can't lift my hand above my waist or reach more than a few inches. Constant pain in my upper arm and shoulder.
Immediately upon being injected, I thought the injection was too high in my arm (had never had an injection that high) and it hurt. Injection site and surrounding area continued to worsen and by evening couldn't move my arm without lifting it with my right arm. Had a bad reaction to the vaccine - fever, malaise, flu-like symptoms which lasted a few days. Over the past 4 months my shoulder has started to get better but still have lingering pain and weakness. Of note, I returned for the 2nd shot on 12/30/21, which was given by a different person and in the right arm instead of the left and experienced no problems or pain at all.
7/6 started w/ fever to 103 for 24 hours. 7/8 am noted mostly flat light red rash on abdomen & flank. Later that day, rash spreading all over torso, legs, groin with hive like appearance and edema of navel & genitals and child irritable. Referred to Urgent Care. was evaluated, per Mom, for MIS-C but Covid negative, blood work and abdominal XR negative except for some gas & stool. Treated with Benadryl. This am  still somewhat fussy and hives but improved. Mom now reporting had a localized hive like rash near navel/diaper line for about one week. Not clear as to exactly when it began.
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 16-DEC-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (rHA) (lot # L012479, expiry date 10-APR-2017, dose and route of administration were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Minor discomfort near injection site within first thirty minutes.  Discomfort increased the following morning:  arm pit area, general body achiness, elevated heart rate during much of the day.
pt recv vax 12DEC95 & 13DEC95 pt exp a dermatological vesicular rash on trunk which appeared to be shingles;
LARGE LOCALIZED REACTION INVOLVING MOST ALL LEFT DELTIOD, ERYTHEMA, SWELLING, PRURITIS, TENDERNESS, AND 3 CM NODULE AT INJECTION SITE.
Patient complained of Headache, chills, fever 102 degrees, beginning 12-13 hours after vaccination. Patient complained of pain in left arm at same time. Symptoms resolved 48 hours later. However, on 10/25/06 patient reported pain left arm and had difficulty lifting left arm. Prescription for Prednisone and analgesic given.
Headache, fever, low wbc (2.4). Follow-up Information: This patient reported on F/U had a positive B swab, so his reaction was not due to Menactra.
Information has been received from a physician concerning a 23 weeks old male with no allergies, who on 19-OCT-2009 was vaccinated with a first dose of ROTATEQ (lot number: 664070/0320Y, route not reported, expiration date: 19-OCT-2009). On 17-DEC-2009 the patient was vaccinated with a second dose of ROTATEQ (lot number: 664291/0769Y and route not reported, expiration date: 27-JAN-2009). The physician reported that the patient developed intussusception after his second dose of ROTATEQ and was hospitalized on 30-JAN-2010 with severe dehydration and was kept in the hospital until his discharge on 01-FEB-2010. The physician stated that "the patient continued to improve after discharge from the hospital and soon felt 100% better. Complete blood count and an ultrasound were performed when the patient was admitted on 30-JAN-2010 to confirm his diagnosis. Also the physician stated that "there were no plans to give the patient third dose of ROTATEQ". Therapy with ROTATEQ was discontinued on 17-DEC-2009.  Intussusception and severe dehydration were considered to be immediately life-threatening.  Additional information has been requested.
Approx. 4 days after the shot I had increasing deep aching pain and muscle wasting in my upper left arm. It has continued to get worse. My physician put me on Keflex for 10 days, 4 times a day. I received the shot on Feb 17th and it has not gotten any better.
pt inadvertently recv two doses of vax 31OCT97 & 3NOV97;pt is unable to communicate & pt could not be certain that had had two doses; Follow up information received July 17, 1998 states vaccinee was reported to have received one dose on October 25 and a second on November 3. There was "no adverse side effects due to administration of two "flu vaccines". Follow up information received 3/02. A mother reported that her 7 year old child received 4th dose of Hib-Titer on Dec 4, 1997 adn within hours, developed a 6-inch hive at the injection site. The patient reportedly subsequently developed hives which "migrated over entire body". The patient was taken to the emergency room. Manufacturer's Comment: The lot number was reported as M330PD, however, this is not a valid Lederle lot number. Follow-up information received from the physician on Oct 23, 2001 provided the patient's birth weight of 8 pounds, 5 ounces, indicated that the patient received no other vaccines within four weeks of Hib-Titer administration, and the patient recovered.
On 10/7/98, the pt developed hives on torso and upper leg. Pt stated that hives are fading away.
Chills; joint pain; muscle aches; diarrhea; extreme fatigue; This is a spontaneous report from a contactable (Patient, self-reported). A 33-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration in Arm Left on 01Mar2021 12:00 (33-years-old, non pregnant at the time of vaccination), as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID-19, prior vaccination. Patient has not been tested for COVID-19, post vaccination. It was reported that the patient received dose 1 via an unspecified route of administration, administered in Arm Left on 06Feb2021 14:00 as 1ST DOSE, SINGLE for covid-19 immunization. On 02Mar2021 04:00, the patient experienced chills, joint pain, muscle aches, diarrhea and extreme fatigue. Patient did not received treatment for an adverse events. Outcome of the events was recovered.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
2/5/21: 1300 started developing an itchy rash. At 1500 where she was gven one dose of diphenhydramine PO 25mg. She said she was having no trouble breathing or swallowing and had no swelling in her lips, tongue, or mouth.
pt presented with drowsiness & delayed response / speech.  On-site medics present.  BP: 119/81, HR: 81, SPO2: 98.1;   RR: 16.  patient transported to the ER vial EMS
This is a prisoner in our Resident Treatment Program with a diagnosis of Unspecified schizophrenia.  He has no medical diagnoses.  This prisoner forgot that he had received his first vaccine on 03/10/2021 and got in line with the National Guard and received his second dose within 10 days.  Prisoner was assessed after realization was made on incident.  No medical complaints or issues.  Weekly monitoring will continue for 3 weeks.
I became so short of breath; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Oct2021 at 12:00 as dose 1, single (Lot number: FF8839) at the age of 74 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DYSPNOEA (non-serious) with onset 09Dec2021, outcome "not recovered", described as "I became so short of breath". The event "i became so short of breath" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dyspnea. Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient walking to her gate at airport, she became so short of breath she had to take a wheelchair for the rest of her trip. Prior to vaccination, patient was not diagnosed with COVID-19.
Site: Swelling at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Tingling in fingers on both hands
No additional AE reported; Office manager reports ROTATEQ was administered after a temperature excursion to 23 patients.; This spontaneous report has been received from an office manager referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were not provided.    On 19-JUL-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) once, (lot number W011279 has been verified to be a valid lot number, expiry date 02-NOV-2023) as prophylaxis (strength, dose, route of administration, and anatomical location, date were not provided) (product storage error).  The rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was stored at a temperature of 9 degree Celcius (C) for the time frame of 1 hour and 32 minutes. There was no previous temperature excursion.  No additional adverse events reported.  This is one of several reports received from the same reporter.
5/5 89y.o. male , history of HTN, OCD, transferred from hospital for thalamic intracranial hemorrhage. Pt was found at group home w/ L sided weakness, L facial droop.
Patient received 3 Astra-Zeneca doses. I, the PharmD, consulted with medical doctor with recommendation patient re-start primary series either with Pfizer Monovalent 12+ or Moderna Monovalent 12+ for 2 doses to complete. I relayed information to the LPN who was consulting family, wife and husband. At the same time there was another Vaccine Adverse Event with a separate patient I was attending to outside of tent. Patient was consulted prior to vaccination by other provider, an ARNP, and she chose after consulting references Pfizer BIVALENT vaccination for patient. The discrepancy was not realized until the Vaccine Manager came up and asked why the husband was indicated as needing to receive PRIMARY series Pfizer Monovalent. Husband had previously received 2 doses of Astra Zeneca. It was explained to patient she had received Booster dose instead. Patient understood and no further discussion or adverse events/symptoms incurred.
neck aches; Headache; This spontaneous case was reported by an other caregiver and describes the occurrence of NECK PAIN (neck aches) and HEADACHE (Headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported). Concomitant products included ADALIMUMAB (HUMIRA AC), COLECALCIFEROL (VITAMIN D 3), POTASSIUM, RABEPRAZOLE SODIUM (ACIPHEX) and CYANOCOBALAMIN (VIT B12).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 31-Mar-2021, the patient experienced NECK PAIN (neck aches) and HEADACHE (Headache). At the time of the report, NECK PAIN (neck aches) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment details not included.
Unable to obtain information at this time. MD's will not provide info per telephone.  1/12/09 Reviewed hospital medical records of 3/23-04/03/2008. FINAL DX: acute inflammatory demyelinating polyneuropathy; Guillain Barre syndrome Records reveal patient was hyporeflexic. Neuro consult & LP done. Tx w/high dose steroids.  Markedly improved initially & was being readied for d/c home when had increased back pain, weakness, muscle spasms, neuropathic pain.  Tx w/IVIGx 5 days.  Improved & transferred to inpatient rehab hospital.  12/23/08 Reviewed rehab hospital medical records of 4/3-4/22/2008. FINAL DX: acute demyelinating polyneuropathy Records reveal patient had been in acute care since 3/23/08 after experienced diarrhea bilateral LE weakness, LE pain,  paresthesia of UE & LE, unable to walk.  Areflexic.  Neuro consult done.  Tx w/steroids & IVIG.  Tx w/antibiotics for UTI.  Improved & d/c to home w/neuro & PCP follow up.
Woke up in the middle of the night in severe pain & swelling in my left breast & all around the nipple. It got worse over the next few days, then began to subside. There?s still tenderness, but recovering. Icing helped reduce the pain. I had a clear mammogram before the vaccine.
Information has been received from a registered nurse concerning a female with drug hypersensitivity to "some antibiotics" who on 10-JAN-2006 was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (lot#650457/0973P).  On 10-JAN-2006 the patient experienced a sore and achy arm that was hot to touch and with swelling halfway down the arm.  Unspecified medical attention was sought.  On approximately 13-JAN-2006, the patient recovered.  Additional information has been requested.
About 40 minutes after inject, had stomach upset, went to gas station across the street, then starting having a tickle in my throat, then coughing, then wheezing, intense headache and sore throat pain like it felt like I swallowed pieces of glass then more wheezing and hard to breathe and losing my voice. Arrived at ER about 1 hour or so after injection time  about 12:35 maybe?, they started IV of steroid, benedryl and pepcid rather quickly I don't remember a lot , was very out of it.  But the medicine worked and swelling went down on tongue and throat and my voice came back. They prescribed steroids, benedryl, pepcid and zofran because I was and still very nauseous. Taking advil for headache. I think i was home by 4 or 4:30.    Still feeling awful today.
Patient notes local swelling, induration, and pruritus. Some tenderness, full range of motion.
Pt states after receiving flu and TDAP injection that she felt tingling sensation in mouth and then as time progressed she felt her throat "tighten" but did not keep her from breathing did not seek any medical attention. First time getting flu vaccine 11-15-11 3:00 pm visit.
Information has been received from a pharmacist concerning a 62 year old female patient with a history of sulfonamide allergy who on 30-APR-2008 was vaccinated SC in the left upper arm with a dose of zoster vaccine live (Oka/Merck). The pharmacist reported that the patient developed an injection site reaction. On the evening of 30-APR-2008 the patient's arm became very red and itchy. The left arm at the injection site "became very warm and slightly swollen" and "kept getting bigger and bigger." The adverse experience began to subside on 04-MAY-2008. At the time of this report, the patient is recovering. No diagnostic labs were performed. No product quality complaint was involved. Additional information has been requested.
Approximately 3-6 weeks post-injection my heels and soles became hot, red, and painful enough to disturb my sleep.  I self treated with ice, analgesics and stretching exercises.  Around that same time period there were pain and burning sensations radiating from the center of my chest, occasional pains in my left arm, sensations of heart palipations or fluttering, and episodes of sweating not brought on by exertion.  The pain was relieved by aspirin.  The discomfort was significant and seemed consistant with heart attack symptoms so I reported my concerns to my Primary Care Provider on June 7, 2021.  Although the chest pain and burning has subsided I still feel a persistant tightness in my chest.
This spontaneous report was received from a Certified Medical Assistant (C.M.A) regarding a 4 year old patient of unspecified gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 19-JUL-2016, the patient was vaccinated with improperly stored PROQUAD (lot # L050910, expiry date 14-JUN-2017) dosing regimen unknown. Call was because of a data logger. It was reported that the vaccine administered was subjected to temperature excursion of 23 degree Celsius for a time frame of 1 hour and 29 minutes. The vaccine was not subjected to any previous temperature excursion. No adverse effect was reported. Product quality complaint (PQC) was not filed. This is one of the several reports received from the same reporter. Additional information has been requested.
tested positive on binax rapid antigen test 10/17/22- asymptomatic, tested as part of follow up to known exposure He has had moderna primary series plus one moderna monovalent booster and pfizer bivalent booster listed above
Patient called pharmacy to state that her arm was red. sore, and swollen from Pfizer vaccine.   she was concerned that administration was not properly done which caused her arm to be red and sore.
About an hour after receiving vaccine pt got chills and 8 hours later 1 bout of diarrhea. Diarrhea resolved but chills less after 6 days. Still had mild chills 9/26/17. Still mild chills 9/26/17. Pt ok now 10/12/17.
we both tested positive for COVID; we both tested positive for COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 as dose 4 (booster), single (Lot number: GL0446) at the age of 65 years for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Lot number: EW0161, Expiration Date: 09Jul2021), on 31Jul2021 as dose 2, single (Lot number: EW0161) and on 04Feb2022 as dose 3 (booster), single (Lot number: FJ5682) for covid-19 immunisation. The patient's relevant medical history included: "Dementia" (ongoing), notes: Dementia; "Hypertension" (ongoing), notes: hypertension at 93-94; "papillary cancer", start date: 1978 (unspecified if ongoing), notes: papillary cancer in 1978; "thyroid", start date: 1978 (unspecified if ongoing), notes: thyroid hit me 1978; "major back surgery" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown", COVID-19 (medically significant) with onset 2023, outcome "not recovered" and all described as "we both tested positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: test for the COVID and fluid and the fluid was negative but the COVID came back positive; (unspecified date) Positive, notes: whole test making us positive; (01Mar2023) Positive, notes: we both tested positive for COVID last night. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course details: The patient never had COVID until this time, was diagnosed in Wednesday of this week, starting of the symptoms on Monday. The patient and his wife went to an emergency medical shop, there was a physician there and they gave a test for the COVID and fluid and the fluid was negative but the COVID came back positive. The patient still had symptoms of COVID; he has back pain, nasal.
vaccine May 15. awoke with chest pain and pain on movement on May 30, 2021. went to urgent care. negative cardiac workup and treated for costochondritis. Second dose on June 5 with pain in chest on June 7. D dimer negative.  EKG and xray negative. treated with naproxen and pain resolved, only to recur when he stopped taking medication on 6/17/21. pain subsequently improved.